A Registered Cohort Study on Duchenne Muscular Dystrophy
ConditionDuchenne Muscular Dystrophy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2+
SponsorNing Wang, MD., PhD.
About this trial
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Beyond 2 years old
Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
Disqualifiers
Presence of other clinically significant illness
Trial population
Patients who are diagnosed as Duchenne Muscular Dystrophy in the hosipital
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Age at death
the time when patient die
Time frame
20 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Ning Wang, MD., PhD.
Lead sponsor
First Affiliated Hospital of Fujian Medical University
Sponsor institution
Source ClinicalTrials.gov